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In this study, we explore endoderm cell fate regulation
through the expression of lineage-determining tran-
scription factors. We demonstrate that stable endo-
derm progenitors can be established from human ES
cells by constitutive expression of SOX7 or SOX17,
producing extraembryonic endoderm and definitive
endoderm progenitors, respectively. In teratoma
assays and growth factor-mediated differentiation,
SOX7 cellsappear restricted to theextraembryonicen-
doderm, and SOX17 cells demonstrate a mesendoder-
mal phenotype in teratomas and the ability to undergo
endoderm maturation in vitro in the absence of cyto-
kine-mediated endoderm induction. These endoderm
progenitor cells maintain a stable phenotype through
many passages in culture, thereby providing new tools
to explore the pathways of endoderm differentiation.
INTRODUCTION
There are two distinct endoderm lineages in the early embryo.
The extraembryonic endoderm (ExEn) differentiates at the blas-
tocyst stage prior to implantation forming an epithelial layer, the
primitive endoderm, that separates the epiblast from the blasto-
coel cavity. The primitive endoderm gives rise to the visceral
endoderm, which overlies the epiblast, and the parietal endo-
derm, which contributes to the primary yolk sac. Commitment
of cells to the ExEn fate occurs prior to overt differentiation, as
measured by expression of the endoderm-specific effector
Gata6 in the inner cell mass at E3.5 (Chazaud et al., 2006).
In the mouse, interactions between the ExEn and epiblast during
gastrulation regulate events such as ectoderm cavitation (Cou-
couvanis and Martin, 1999), axis specification (Rossant and
Tam, 2004; Tam et al., 2006), and yolk sac-mediated nutrient
delivery (Yoder et al., 1994). The definitive endoderm (DE) of
the embryo proper arises at gastrulation from the epiblast follow-
ing ingression of cells through the anterior primitive streak. DE
specification is mediated by Nodal signaling and induction of
the transcription factors Mixl1 and Sox17 (Hart et al., 2002;
Kanai-Azuma et al., 2002). Cells of the DE later differentiate to
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to the gastrointestinal and respiratory tracts and associated
organs such as the liver and pancreas (Tam et al., 2003).
The promise of HESC in the field of regenerative medicine re-
lies on understanding lineage specification in vivo so that these
processes can be exploited to control HESC differentiation.
In addition to attempts to recapitulate differentiation via growth
factors and culture environment, several studies have utilized
transcription factor modulation as a mechanism to control down-
stream signaling cascades. ExEn differentiation can be induced
in mouse ESC by ectopic expression of Gata4 or Gata6 (Fujikura
et al., 2002). Considered a master regulator of the pancreatic lin-
eage, PDX1 expression has been explored in HESC (Lavon et al.,
2006) and for transdifferentiation of human hepatocytes to b cells
(Ber et al., 2003; Ferber et al., 2000; Sapir et al., 2005). PDX1,
however, induced only a small number of insulin-positive cells.
Whereas expression of forkhead box A2 (FoxA2) in mouse
ESC enhanced expression of early endoderm transcription
factors (Levinson-Dushnik and Benvenisty, 1997), expression
of FOXA2 in HESC did not promote pancreatic differentiation
(Lavon et al., 2006). Transient expression of Pax4 in mouse
ESC increased levels of Pdx1, somatostatin, and glucose-re-
sponsive insulin secretion (Lin et al., 2007), and recent studies
demonstrate that constitutive expression of PAX4 enhances
b cell differentiation in HESC (Liew et al., 2008).
The majority of extant studies have concentrated on differen-
tiation of ESC toward mature endodermal derivatives. We in-
stead hypothesized that stable endoderm progenitors could be
established from HESC through the controlled expression of
early regulators of endoderm specification. We focused on
SOX7 and SOX17, which are implicated in endoderm determina-
tion and maintenance. Work in mouse embryonal carcinoma (EC)
cells established the requirement of Sox7 for the induction of
Gata4 and Gata6 and subsequent ExEn differentiation (Futaki
et al., 2004). In Xenopus, vegetally localized Sox7 activates Nodal
expression and genes involved in mesendoderm differentiation
(Zhang and Klymkowsky, 2007). Whereas expression of Sox7
is restricted to the mouse ExEn during early embryogenesis,
Sox17 expression localizes to both the ExEn and the DE
(Kanai-Azuma et al., 2002). In Xenopus and mouse, Sox17 is re-
quired for differentiation of the DE and development of its deriv-
ative structures (Hudson et al., 1997; Kanai-Azuma et al., 2002).
Although Sox17/ mice do not exhibit an ExEn phenotype,
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SOX7 and SOX17 Regulate Endoderm Differentiationstudies suggest that Sox17 contributes to later differentiation of
the visceral and parietal endoderm (Shimoda et al., 2007). The
detection of Sox7 and Sox17 in the embryonic mouse pancreas
suggests that their sustained expression may also function more
broadly in endoderm organogenesis (Lioubinski et al., 2003).
Here, we explore the roles of SOX7 and SOX17 as regulators
of endoderm differentiation in HESC. CA1 and CA2 HESC were
engineered to ectopically express SOX7 or SOX17, and the re-
sulting phenotype was assessed in maintenance cultures and
following in vitro differentiation. SOX7 overexpressing (O/E) HESC
demonstrated an epithelial-like morphology and expression of
markers of the ExEn, a phenotype reinforced by exposure to
BMP4. SOX17 O/E HESC cells demonstrated patterns of gene
expression similar to that of the DE and the ability to differentiate
toward hepatic and pancreatic derivatives in the absence of
Activin A-mediated DE induction. We demonstrate that expres-
sion of a single SOX transcription factor is sufficient to induce
differentiation of HESC to stable, proliferative cells demonstrat-
ing the phenotype of early endoderm progenitors.
RESULTS
Expression of SOX Transcription Factors in HESC
To assay whether constitutive expression of lineage-determining
transcription factors in HESC cells could promote the differenti-
ation of endoderm-specific progenitors, cell lines conditionally
expressing SOX7 or SOX17 were established from CA1 and
CA2 HESC. SOX7 or SOX17 cDNAs were introduced to HESC
via pClip, a Cre-inducible expression vector. The pClip vector
utilizes the CAG promoter to initially drive expression of a floxed
bGeo-polyA, enabling the selection of stable clones via neomy-
cin resistance. Following Cre-mediated excision of the floxed
bGeo-polyA, CAG-driven expression of the SOX7 or SOX17
cDNAs can be selected for via puromycin resistance (designated
SOX7 O/E and SOX17 O/E) (Figure 1A). Multiple clones contain-
ing single transgene integrations demonstrated consistent mor-
phology following O/E of either SOX7 (n = 5) or SOX17 (n = 4).
Two representative clones with similar levels of SOX7or SOX17
expression were used in all subsequent experiments. Expression
of SOX7 or SOX17 was quantified by real-time PCR (Figures 1C
and 2B) and immunostaining to confirm nuclear localization of
the expressed protein (Figures 1D and 2C). The respective
conditional parental lines (No CRE) served as controls in all
cases, as no significant differences in gene expression profiles
were observed when compared to the CA1/CA2 HESC
(Figure S1 available online).
The phenotypes of SOX7 and SOX17 O/E HESC lines were
evaluated following Cre-mediated induction. SOX7 O/E induced
differentiation of HESC to a flattened epithelial morphology
within the first passage (Figure 1B), with concomitant expression
of the pan-endodermal markers GATA4 and SOX17 and the
ExEn marker a-fetoprotein (AFP) (Figure 1D). Expression of the
pluripotency markers OCT4 and NANOG remained detectable
in SOX7 O/E HESC, demonstrating an ExEn phenotype (Figures
1E and 4C). SOX17 O/E HESC exhibited HESC-like morphology,
although within colonies, cells were less dense with distinct cell
boundaries (Figure 2A). SOX17 O/E HESC showed increased ex-
pression of GATA4 (Figure 2C) and persistent expression of
OCT4 and NANOG (Figures 2D and 4C). Expression of theExEn markers SOX7 and AFP was not detected in SOX17 O/E
HESC. SOX7 and SOX17 O/E HESC have been cultured for
greater than 50 passages and demonstrate consistent morphol-
ogies and population doubling times of 35.7 ± 4.3 hr and 26.4 ±
2.9 hr, compared to 18.5 ± 1.1 hr in control HESC.
SOX7 O/E HESC Are Lineage Restricted, whereas
SOX17 O/E HESC Remain Multipotent
To assess the ability of SOX7 and SOX17 to regulate HESC
potential, cells were subjected to teratoma assays. Tumors har-
vested following injections with control HESC contained a het-
erogeneous mixture of mesoderm (cartilage, bone), endoderm
(stratified epithelial and glandular structures), and ectoderm
tissues (neural epithelia) (Figure 3A, left panel). In contrast, tu-
mors resulting from SOX7 O/E HESC injection were smaller
and consisted of large epithelial structures with no evidence of
mesoderm or ectoderm derivatives (middle panel). Tumors
formed by injection of SOX17 O/E HESC contained a mixture
of mesodermal and endodermal structures with no evidence of
ectoderm (right panel). Thus, whereas expression of SOX7
restricts lineage specification of HESC, SOX17 O/E HESC
demonstrate multilineage differentiation in vivo.
To verify that SOX7 and SOX17 O/E HESC are restricted from
neuronal differentiation, cells were subjected to an established
protocol for in vitro neuroectoderm differentiation (Pankratz
et al., 2007). Whereas control HESC demonstrated increased
expression of the neuronal markers NESTIN, SOX1, SOX3, and
PAX6 following differentiation, induction of neuronal markers
was not detected in either SOX7 or SOX17 O/E HESC, thereby
confirming a lineage restriction (Figure 3B). Furthermore, SOX7
O/E cells maintained the expression of ExEn genes, and
SOX17 O/E cells maintained the expression of DE genes follow-
ing exposure to in vitro neural differentiation (Figure S2).
SOX7 and SOX17 O/E HESC Demonstrate Distinct
ExEn and DE Phenotypes
Microarray-based expression profiling examined in detail the
phenotypes of SOX7 and SOX17 O/E HESC. Two individual lines
of each were used to probe Affymetrix GeneChips, and expres-
sion was evaluated relative to respective No CRE controls. SOX7
and SOX17 O/E HESC displayed distinct profiles of gene expres-
sion (Figure 4). There were 732 significantly upregulated probes
that were unique to SOX7 O/E HESC, including ExEn markers,
LAMB1,COLIV,HSPG2, and SPARC (Hogan et al., 1980; Mason
et al., 1986; Semoff et al., 1982). A subset of 1683 significantly
upregulated probes were unique to SOX17 O/E HESC and
included DE markers such as CXCR4, KRT8, BMP2, and
GATA3 (Debacker et al., 1999; McLean et al., 2007; Sherwood
et al., 2007). There were 389 significantly upregulated probes
that were common to SOX7 and SOX17 O/E HESC; they in-
cluded the pan-endodermal markers GATA4, GATA6, HNF4A,
and FOXA2, which are expressed in both the ExEn and DE
(Grapin-Botton and Constam, 2007).
Real-time PCR confirmed gene expression profiles, demon-
strating expression of pan-endodermal markers (GATA4,
GATA6, HNF4A, FOXA2, and SOX7) in SOX7 and SOX17 O/E
HESC and divergent expression of ExEn and DE markers (Fig-
ure 4B). SOX7 O/E HESC expressed the ExEn markers AFP,
LAMB1, vHNF1, and SOX7, genes not significantly upregulated
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SOX7 and SOX17 Regulate Endoderm DifferentiationFigure 1. SOX7 O/E HESC Demonstrate a Distinct Morphology and the Expression of ExEn Markers
(A) Properties of the pClip expression system used for generation of conditional and SOX O/E HESC. Clonal cell populations were established by neomycin
resistance and transgene expression induced following Cre-mediated recombination.
(B and B0) Photomicrographs of HESC cultures prior to (B) and following (B0 ) Cre induction of SOX7 expression.
(C) Relative expression of SOX7 prior to (No CRE) and following (SOX7 O/E) Cre-mediated induction determined by real-time PCR. Data are presented as mean ±
SEM from two representative SOX7 O/E cell lines, each measured following three independent Cre inductions.
(D) Fluorescence micrographs demonstrate expression of SOX7, SOX17, GATA4, and AFP (red) in SOX7 O/E and control HESC.
(E) Coexpression of SOX7 (green) and NANOG (red), as well as OCT4 (green) and AFP (red), in SOX7 O/E HESC. Scale bars, 200 mM.184 Cell Stem Cell 3, 182–195, August 7, 2008 ª2008 Elsevier Inc.
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SOX7 and SOX17 Regulate Endoderm DifferentiationFigure 2. SOX17 O/E HESC Express Endoderm Markers but Are Morphologically Distinct from SOX7 O/E Cells
(A and A0) The morphology prior to (A) and following (A0 ) Cre-mediated induction of SOX17 O/E in HESC.
(B) Relative expression of SOX17 following Cre-mediated induction. Data are presented as the mean ± SEM from two representative SOX7 O/E cell lines, each
measured following three independent Cre inductions.
(C) Fluorescence micrographs demonstrate the expression of SOX17 (red) and GATA4 (red) in SOX17 O/E and control HESC.
(D) Coexpression of SOX17 (green) and NANOG (red), as well as OCT4 (green) and GATA4 (red), in SOX17 O/E HESC. Scale bars, 200 mM.in SOX17 O/E HESC. Conversely, SOX17 O/E HESC demon-
strated robust expression of the DE markers CXCR4, CER,
GSC, and DLX5, as well as ECAD and FOXQ1, genes not ex-
pressed in SOX7 O/E HESC. These findings demonstrate the
distinct phenotype of SOX7 and SOX17 O/E HESC and suggest
they represent progenitors with predisposition to the ExEn and
DE, respectively.
Lineage Specification of SOX7 O/E and SOX17
O/E HESC
To explore their developmental potential in vitro, SOX7 and
SOX17 O/E HESC were compared in cytokine-mediated differen-
tiation assays. BMP induces ExEn and trophectoderm differenti-
ation from HESC (Pera et al., 2004; Xu et al., 2002), and Activin A
promotes DE differentiation (D’Amour et al., 2005). A significant
increase in the expression of the ExEn markers AFP, LAMB1,vHNF1, and SOX7 was observed in SOX7 O/E HESC when com-
pared to control HESC following BMP4 treatment (Figure 5A). Ac-
tivin A treatment increased expression of the DE markersCXCR4,
CER, GSC, and DLX5 in SOX17 O/E HESC when compared
to control HESC (Figure 5B). However, ExEn genes were not ex-
pressed in BMP4-treated SOX17 O/E HESC, and DE genes were
not induced by Activin A in SOX7 O/E HESC. Interestingly, BMP4
treatment of SOX17 O/E HESC induced DE markers, and Activin
A treatment of SOX7 O/E HESC induced ExEn markers (Figures
5A and 5B), indicating rigidity in the differentiation pathways
available to SOX7 and SOX17 O/E HESC.
Levels of SOX7 and SOX17 were assayed in control and SOX
O/E cells. SOX7 mRNA and protein levels were detected in
HESC following 5 days of BMP4 treatment and were further
upregulated by BMP4 in SOX7 O/E HESC (Figures 5A and 5C).
Similarly, whereas Activin A promoted SOX17 expression in
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SOX7 and SOX17 Regulate Endoderm DifferentiationFigure 3. Lineage Restriction of SOX7 and SOX17 O/E HESC
(A) H&E-stained tissue sections demonstrating the composition of teratomas resulting from the injection of control HESC, SOX7, or SOX17 O/E HESC. (Left) Plu-
ripotency of HESC demonstrated by mesodermal (asterisk indicates cartilage), endodermal (arrowheads indicate epithelial and glandular structures), and ecto-
dermal tissues (arrows indicate neuroectoderm). (Center) Tumors derived from SOX7 O/E HESC are composed uniquely of large epithelial structures. (Right)
Tumors derived from SOX17 O/E HESC demonstrate mesodermal (asterisks) and endodermal (arrowheads) structures. Scale bars, 200 mM.
(B) Real-time PCR analysis of gene expression in untreated HESC, SOX7, and SOX17 O/E HESC (gray) compared to cells subjected to neuronal differentiation
(black). Data are presented as the mean ± SEM from triplicate experiments in representative cell lines, normalized to untreated controls.HESC, mRNA and protein levels in SOX17 O/E HESC were
further upregulated by Activin A (Figures 5B and 5C). The per-
centage of HESC undergoing endoderm differentiation was
quantified by FACS. Differentiation toward ExEn was detected
in BMP4-treated HESC, as reflected by AFP expression in
83.73% of the population. SOX7 O/E likewise induced ExEn dif-
ferentiation, producing a population of cells in which 89.13%
were AFP+, and, following BMP4 treatment, 92.62% of the
population was AFP+. The expression of AFP in SOX17 O/E
HESC did not differ from control HESC (Figure 5D). DE differen-
186 Cell Stem Cell 3, 182–195, August 7, 2008 ª2008 Elsevier Inc.tiation was assessed by quantifying CXCR4/cKit coexpression.
Whereas Activin A induced DE differentiation in approximately
one-third of control HESC, DE differentiation was detected in
78.51% of SOX17O/E HESC in the absence of Activin A
treatment. The percentage of CXCR4+/cKit+ cells was not signif-
icantly increased in SOX17 O/E cells following Activin A treat-
ment, but CXCR4 expression increased in a subset of cells
(Figure 5E).
To determine whether cells representative of other lineages
were present, markers of trophectoderm and mesoderm were
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SOX7 and SOX17 Regulate Endoderm DifferentiationFigure 4. SOX7 and SOX17 O/E HESC Are Phenotypically Distinct and Enriched for Markers of the ExEn and DE, Respectively
(A) Venn diagram of overlapping and specifically upregulated genes in SOX7 and SOX17 O/E HESC. DNA microarrays identified probes upregulated in two rep-
resentative lines of SOX7 or SOX17 O/E HESC. Partial list of marker genes is shown, along with the average fold change of representative probe sets. Significance
was assigned with a p value < 0.003.
(B) The ExEn and DE phenotypes of SOX7 and SOX17 O/E HESC verified by real-time PCR. Expression of ExEn markers, DE markers, pan-endodermal markers,
and pluripotency markers quantified in SOX7 and SOX17 O/E HESC. Data are presented as the mean ± SEM from representative cell lines measured following
three independent Cre inductions.examined. BMP4 increased expression of the trophectoderm
markers CDX2 and HCG in control HESC; however, similar in-
creases were not observed in SOX7 O/E HESC (Figure S3).
Although a moderate increase in CDX2 expression was ob-
served in SOX17 O/E HESC following BMP4 or Activin A treat-
ment, this likely represents the presence of gut tube derivatives,
as there was no concomitant induction of HCG expression.
Activin A promoted BRA expression in SOX17 O/E HESC,a gene associated with the early mesendoderm-to-DE transition
(Kispert and Herrmann, 1994). In contrast, BRA expression
was not induced in SOX7 O/E HESC. Loss of OCT4 was ob-
served in all cell lines following 5 days of growth factor treatment
(Figure S3).
To ensure that the phenotypes of SOX7 and SOX17 O/E HESC
were stable, differentiation assays were repeated following 20
passages (p.20) (Figure S4). The expression of ExEn markersCell Stem Cell 3, 182–195, August 7, 2008 ª2008 Elsevier Inc. 187
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SOX7 and SOX17 Regulate Endoderm DifferentiationFigure 5. SOX7 O/E HESC Are Restricted to the ExEn Lineage, whereas SOX17 O/E HESC Are Restricted to DE
(A and B) Real-time PCR analysis evaluating the expression of ExEn and DE markers in (A) SOX7 O/E HESC or (B) SOX17 O/E HESC and control HESC following
5 days of 20 ng/ml BMP4 or 50 ng/ml Activin A.
(C) Immunoblot analysis demonstrates protein levels of SOX7 in control and SOX7 O/E HESC following 5 day BMP4 treatment and SOX17 levels in control and
SOX17 O/E HESC following 5 day Activin A treatment.
(D) Flow cytometric analysis of ExEn differentiation, as assessed by AFP expression, in control and SOX O/E HESC.
(E) Flow cytometric analysis of DE differentiation, as measured by the CXCR4+/cKit+ population in control and SOX17 O/E HESC.persisted in p.20 SOX7 O/E HESC and was increased by BMP4,
and expression of DE markers was not detected (Figure S4A).
Conversely, DE markers were expressed in p.20 SOX17 O/E
HESC and further upregulated by Activin A, and ExEn markers
were not induced (Figure S4B). These findings suggest that
SOX7 and SOX17 O/E HESC represent stable cell lines predis-
posed to the ExEn and DE, respectively.
188 Cell Stem Cell 3, 182–195, August 7, 2008 ª2008 Elsevier Inc.In Vitro Differentiation of SOX17 O/E HESC
to DE Derivatives
We next assayed whether the apparent DE phenotypes of
SOX17 O/E HESC would enhance their ability to differentiate
to endoderm derivatives such as hepatocytes and pancreatic
endocrine cells in vitro. We assessed the ability of SOX7
and SOX17 O/E HESC to undergo hepatic differentiation using
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Activin A (stage 1), followed by FGF4 and BMP2-mediated
hepatic induction (stage 2) and hepatic maturation in the pres-
ence of HGF, OSM, and dexamethasone (stage 3) (Cai et al.,
2007). The expression of stage-specific markers was compared
between SOX17 O/E and control HESC (Figure 6). In response to
Activin A, both cell lines increased SOX17 and CXCR4 expres-
sion, followed by the early hepatic markers keratin 18 (KRT18)
and AFP (Figure 6A) in stage 2. Sox17 O/E HESC demonstrated
more efficient hepatic differentiation than control HESC, as mea-
sured by significant increase in the expression of tyrosine amino-
transferase (TAT), tryptophan 2,3-dioxygenase (TDO2), and
albumin (ALB) in stage 3.
We reasoned that, if SOX17 O/E HESC represent DE progen-
itors, the initial induction of DE by Activin A, a step required for
hepatic differentiation from HESC (Cai et al., 2007), should be
dispensable (Figure 6B). Interestingly, expression of the late he-
patic markers AFP and ALB was significantly increased in
SOX17 O/E HESC not exposed to Activin A when compared to
SOX17 O/E HESC subjected to the full differentiation protocol.
Efficient hepatic differentiation in the absence of Activin A-medi-
ated DE induction was likewise demonstrated by the uniform
immunolocalization of both AFP and ALB in SOX17 O/E HESC
(Figure 6C). SOX7 O/E HESC were likewise subjected to in vitro
hepatic differentiation to evaluate their potential. Interestingly,
the culture conditions induced population-level cell death follow-
ing the first stage of the differentiation protocol (data not shown).
The propensity of SOX7 and 17 O/E HESC to differentiate to
endocrine pancreatic cells was assessed using stepwise growth
factor stimulation to promote differentiation from DE (Activin A,
Wnt3A), primitive gut tube (FGF10, Hedgehog inhibition), and
posterior foregut (FGF10, retinoic acid, Hedgehog inhibition)
through to hormone-expressing endocrine cells (D’Amour
et al., 2006). In addition to the sustained expression of SOX17,
SOX17 O/E HESC increased expression of the DE markers
CXCR4 andCER, the posterior foregut markerPDX1, and the en-
docrine hormones glucagon (GCG) and somatostatin (SST)
when compared to control HESC (Figure 7A). The most striking
increase in expression of end-stage markers was, however,
elicited when SOX17 O/E HESC were subjected to pancreatic
differentiation in the absence of Activin A-mediated DE induction
(Figure 7B). When compared to cells subjected to the full proto-
col, SOX17 O/E HESC showed more robust differentiation
toward hormone-expressing cells in the absence of Activin A
treatment, as assayed by expression of insulin (INS) mRNA
and the detection of INS-positive cell clusters (Figure 7C). The
production of cells expressing markers of the endocrine pan-
creas was further validated by the colocalization of PDX1 or
c-peptide with SOX17 in the absence of Activin A-mediated DE
induction (Figure 7D).
In contrast to the SOX17 O/E HESC, SOX7 O/E appears to limit
the ability of HESC to undergo differentiation toward a pancreatic
endocrine phenotype. In addition to expressing lower levels of
SOX17 and CXCR4 when compared to SOX17 O/E HESC,
SOX7 O/E cells did not demonstrate induction of PDX1, INS, or
SST following in vitro differentiation (Figure S5). Interestingly,
SOX7 O/E HESC demonstrated HNF6 and GCG expression in
the later stages of differentiation, provided that they were first
induced with Activin A.The proclivity of SOX17 O/E HESC to produce cells expressing
markers of endodermal derivatives in vitro, most notably in the
absence of DE induction, substantiates expression-profiling
data, suggesting they represent early DE progenitors.
DISCUSSION
Through genetic manipulation of HESC, the current study sup-
ports the roles of SOX7 and SOX17 as endoderm lineage-deter-
mining factors and demonstrates how constitutive transcription
factor expression can produce different types of endoderm pro-
genitors from HESC. Treatment of HESC with BMP4 has been
reported to induce both ExEn (Pera et al., 2004) and trophecto-
derm differentiation (Xu et al., 2002); heterogeneous differentia-
tion, likewise, was detected in the current study. Initial attempts
to generate mature DE derivatives, such as hepatic and pancre-
atic cells from HESC, relied on spontaneous differentiation in
three-dimensional cultures, followed by the isolation of progen-
itor cells and growth factor-induced maturation (Assady et al.,
2001; Jiang et al., 2007a, 2007b; Lavon et al., 2004; Schwartz
et al., 2005; Shirahashi et al., 2004). More recent studies
described effective Activin A-mediated DE differentiation of
HESC (D’Amour et al., 2005), enabling the development of step-
wise protocols for the production of endocrine pancreas and
hepatocytes (Cai et al., 2007; D’Amour et al., 2006; Kroon
et al., 2008). Although promising, these approaches are limited
by initial production of heterogenous populations with restricted
cell proliferation and limited production of mature functional
cells. Here, we show that SOX7 and SOX17 O/E cells represent
stable endoderm progenitor cell lines that can be expanded in
culture and used to explore the processes regulating endoderm
differentiation.
The ExEn progenitor population derived by constitutive SOX7
expression demonstrates a gene expression profile similar to
that of mouse blastocyst-derived ExEn (XEN) cells (Kunath
et al., 2005), as well as EC parietal endoderm cells (Futaki
et al., 2003). All three populations express the basement mem-
brane components laminin, collagen IV, and perlecan, as well
as endoderm transcription factors vHNF1, FoxA2, Gata4,
Gata6, and Sox17, suggesting that SOX7 O/E HESC represent
the human counterpart of the established mouse cell lines.
Similar to XEN cells, SOX7 O/E HESC express markers of both
the visceral endoderm (HNF4a, AFP) and parietal endoderm
(LAMB1, SNAIL1) and, therefore, may represent a mixture of
ExEn derivatives. Previous studies had suggested Gata4 and
Gata6 as master regulators of ExEn differentiation. Gata4 and
Gata6 null mice show defects in ExEn development, and deriva-
tive ESC fail to generate ExEn (Kuo et al., 1997; Morrisey et al.,
1998; Soudais et al., 1995). In addition, expression of Gata4 or
Gata6 in mouse ESC induced ExEn differentiation (Fujikura
et al., 2002). The current study places SOX7 upstream of
GATA4 and GATA6 in ExEn differentiation, similar to ExEn differ-
entiation of EC cells (Futaki et al., 2004). Contrary to the current
study, however, Sox7 expression in mouse EC cells was insuffi-
cient to drive ExEn specification. This discrepancy may reflect
intrinsic differences between HESC and mouse EC cells but
may also be attributed to differences in Sox7 levels, as threshold
effects are known to limit the ability of transcription factors to
promote lineage specification (Fujikura et al., 2002). The current
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SOX7 and SOX17 Regulate Endoderm DifferentiationFigure 6. SOX17 O/E HESC Undergo Efficient In Vitro Hepatic Differentiation
(A) Real-time PCR analysis of control HESC (gray bars) and SOX17 O/E (black bars) subjected to hepatic differentiation.
(B) Gene expression analysis of control and SOX17 O/E HESC subjected to hepatic differentiation without Activin A-mediated DE induction (step 1). Data are
presented as the mean ± SEM from triplicate experiments in representative cell lines, normalized to untreated controls.
(C) Immunolocalization of SOX17, AFP, and ALB in control and SOX17 O/E HESC following hepatic differentiation without Activin A-mediated DE induction. Scale
bars, 200 mM.190 Cell Stem Cell 3, 182–195, August 7, 2008 ª2008 Elsevier Inc.
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way, findings supported by the expression of Sox7 in the ExEn
of Sox17/ mice and the putative function of Sox17 as a late
effector of ExEn maturation (Shimoda et al., 2007). However,
our findings dispute the model of ExEn differentiation proposed
in the latter study, which postulated redundant roles for Sox7
and Sox17 during ExEn maturation. Further investigation is re-
quired to identify SOX7 binding targets in HESC and dissect
the pathway of ExEn specification. As a proliferative source of
lineage-committed cells, these ExEn progenitors will provide
useful tools to investigate the interactions between epiblast
and ExEn in the human embryo and the implications for driving
therapeutic lineage differentiation.
The DE phenotype suggested by transcriptional profiling of
SOX17 O/E HESC was verified using established protocols for
hepatic and pancreatic differentiation, where these cells under-
went efficient differentiation in the absence of initial cytokine-
mediated DE induction. We hypothesize that the homogeneous
nature of SOX17 O/E HESC contributes to their efficient differen-
tiation and that the constitutive expression of SOX17 maintains
a nuclear environment primed for later endoderm differentiation.
For example, sustained SOX17 expression induced persistent
PDX1 expression during pancreatic maturation, a transcriptional
activator of insulin and somatostatin expression (Hui and
Perfetti, 2002). Although it is not known whether PDX1 is a direct
target of SOX17, its absence in Sox17/ mice suggests it lies
downstream of SOX17 during pancreatic differentiation and
may facilitate the maturation of insulin-expressing b cells.
Despite increased efficiency for in vitro DE maturation, SOX17
O/E HESC are not restricted to the endoderm lineage, as cells
demonstrated multipotent differentiation in teratomas. In the
mammalian embryo, it is unknown whether early DE cells remain
multipotent. Fate-mapping studies established that, following
migration through the primitive streak, the fates of early
and late DE cells are distinct (Lawson et al., 1986; Lawson and
Pedersen, 1987); however, coculture experiments show that
these cells are not fully committed (Deutsch et al., 2001; Wells
and Melton, 2000). We suggest that SOX17 O/E HESC represent
an early mesendodermal precursor population susceptible to
further growth factor-induced specification. Consistent with
this broader role, Sox17 is required later in development for
the specification of cardiac mesoderm (Liu et al., 2007; Martin
et al., 2004) and the maintenance of fetal hematopoietic stem
cells (Kim et al., 2007).
Interestingly, cultures of SOX7 and SOX17 O/E HESC maintain
expression ofOCT4andNANOG. Whereas theexpressionof these
pluripotency markers is rapidly lost following growth factor-medi-
ated differentiation (Figure S5), their persistent expression in SOX
O/E HESC may contribute to the maintenance of the precursor
phenotype of cells in culture by preventing terminal differentiation.
Further studies are required to investigate the role of persistent
OCT4 and NANOG expression in SOX7 and SOX17 O/E HESC.
We have utilized the transcriptional programs regulating endo-
derm cell identity to generate endoderm progenitor cells with the
ability to be expanded in vitro while retaining endoderm-specific
function. Though such genetically modified progenitor lines are
not likely themselves to be used for therapeutic purposes, these
homogenous endoderm progenitors will be useful substrates for
further improvement of the differentiation protocols required togenerate truly functional mature endoderm derivatives for in vitro
applications such as screening of pharmacological compounds
on mature human cells. In addition, the derivation of pluripotent
cells from human fibroblasts via transcription factor delivery has
brought to the forefront discussions concerning the generation
of patient-specific cells through genetic manipulation (Takahashi
et al., 2007; Yu et al., 2007). Understanding the transcriptional
networks that regulate lineage specification, therefore, becomes
of utmost importance to identifying factors that enable the
reprogramming of autologous adult cells for the repair of
damaged tissues.
EXPERIMENTAL PROCEDURES
Plasmid Construction
The open reading frame (ORF) corresponding to the human SOX7 gene was
amplified by PCR from IMAGE clone 6459570 using the following primers:
Fwd 50-ATGGCTTCGCTGCTGGGA GC-30, Rev 50-CTATGACACACTGTAGC
TGT-30. The SOX17 ORF was amplified by PCR from RNA extracted from
SOX7 O/E HESC using primers designed to incorporate 50 XhoI and 30 NotI
restriction enzyme sites: Fwd 50-CTCGAGGGAGCGCCATGAGCA GCCC
G-30 and Rev 50-GCGGCCGCGCAGGG ACCTGTCACACGTCA-30. SOX7
and SOX17 ORFs were introduced into the pCLIP expression plasmid contain-
ing a CAG promoter (CMV enhancer combined with chicken b-actin promoter),
a loxP-flanked bgeo (b-galactosidase neomycin fusion gene) and three polya-
denylation signals, a multiple cloning site (MCS), and an independent ribo-
somal entry site (IRES) puromycin-polyA cassette (George et al., 2007;
Figure 1A). This construct confers neomycin resistance and lacZ expression
in parental cell lines, and, following Cre recombinase-mediated excision of
bgeo, cells become puromycin resistant and express the gene of interest.
The SOX7 ORF were introduced to the NotI site, and the SOX17 ORF were in-
troduced into XhoI/NotI sites; both constructs were verified by sequencing.
Cell Culture
CA1 and CA2 HESC were maintained on mitotically inactivated mouse embryo
fibroblast feeders in knockout DMEM (GIBCO) with 15% serum replacement
(GIBCO), glutamax (Invitrogen), penicillin/streptomycin (GIBCO), 1 mM nones-
sential amino acids (GIBCO), 0.5 mM mercaptoethanol, and 10 ng/ml FGF2
(Peprotech). For selection of transgenic populations, parental cell lines (No
CRE) were cultured in media containing G418 (GIBCO, 50 mg/ml) and SOX
O/E cell lines in media containing Puromycin (Sigma, 0.8 mg/ml). Cells were
passaged by enzymatic dissociation (0.05% Trypsin, GIBCO) at a ratio
of 1:9 every 4–6 days. SOX7 and SOX17 O/E HESC lines were generated
from both CA1 and CA2. Plasmid DNA was introduced into HESC by
electroporation (170 V, 1050 mF). Neomycin-resistant colonies were picked,
expanded, and screened for single plasmid integration events by Southern
blot. Five SOX7 O/E and four SOX17 O/E clonal populations were expanded.
Transgene expression was induced following electroporation with a CRE re-
combinase vector (pCAGGS-NLS-CRE) and selection for puromycin resis-
tance. Data presented for SOX O/E HESC were generated from replicate
experiments using two representative lines with similar midrange levels of
transgene expression, and parental lines (No CRE) were used as control. Pop-
ulation doubling times were calculated using cell counts obtained between 24
and 48 hr from triplicate cultures using the formula PD = (t2  t1) 3 [log(2)/
log(N2/N1)], where N equals the number of cells at each time point.
Teratomas
For teratoma formation, cells were detached from the feeder layer, and 5 3
106 cells were injected into the testicular capsule of 4- to 6-week old NOD-
SCID mice (NOD/NCrCrl-Prkdcscid). Following 8 weeks, mice were sacrificed,
and the tissues were removed, formalin fixed, and paraffin embedded prior to
sectioning and H&E staining.
In Vitro Differentiation Assays
BMP-4 (20 ng/ml, R&D) or Activin A (50 ng/ml, Peprotech) were added to the
basal culture media 24 hr after cell seeding, and cells were maintained for
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confluent cultures of SOX7 or SOX17 O/E HESC using published protocols
for the production of hepatocytes (Cai et al., 2007), pancreatic cells (D’Amour
et al., 2006), or primitive neuroectoderm (Pankratz et al., 2007).
Immunostaining
Cells were fixed in 4% (w/vol) paraformaldehyde for 15 min at room tempera-
ture, rinsed twice in PBS, and blocked for 1 hr in PBST (PBS 0.1% Triton X-100
[Sigma]) 5% fetal bovine serum (FBS) (Multicell, Wisent). Antibodies were di-
luted in PBST/5% FBS, and primary antibodies were incubated overnight at
4C followed by secondary antibody incubation for 1 hr at room temperature.
For nuclear staining, 1 ug/ml Hoechst 33258 (Sigma-Aldrich) was added in
PBST for 10 min. The following antibodies and dilutions were used: anti-
Sox7 1:100 (R&D, clone 288610), anti-Sox17 1:100 (R&D, clone 245013),
anti-Gata4 1:200 (Santa Cruz, SC-9053), anti-AFP 1:100 (R&D, clone
189502), anti-nanog 1:400 (ReproCELL Inc), anti-OCT3/4 1:400 (Santa Cruz
C-10), anti-ALB 1:200 (Dako, clone A0001), anti-SST 1:300 (Dako, clone
A0566), anti-INS 1:100 (Dako, clone A0564), anti-PDX1 1:10000 (gift from Chris
Wright), anti-c-peptide 1:10000 (clone AB1921, University of Iowa Hybridoma
Bank), Alexa Fluor 488 anti-mouse IgG and anti-rabbit IgG 1:400 (Molecular
Probes), and Cy5 anti-rabbit IgG and anti-mouse IgG 1:400(Jackson Immu-
noResearch).
Gene Expression Analysis
Total RNA was isolated (Trizol Reagent, GIBCO BRL), and 1 mg was reverse
transcribed (QuantiTect RT Kit, Quiagen) according to the manufacturer’s in-
structions. Gene expression was assessed by real-time PCR using the Roche
LightCycler 480. PCR reactions were run in triplicate using 200 ng cDNA per
reaction and 400 uM forward and reverse primers (Table S1) with 2X SYBR
master mix (Roche) and 50 cycles of amplification (95C 10 s; 60C 10 s;
72C 10 s). Specificity of primers was determined by melt curve analysis,
and standard curves were generated to control for primer efficiency. Gene ex-
pression was determined by relative quantification with values corrected for
input using TBP and normalized relative to control HESC.
Global gene expression was assessed in replicate lines of SOX7 and SOX17
O/E HESC and No Cre controls. Total RNA was extracted (Trizol Reagent,
GIBCO BRL) and converted to cDNA using GeneChip One-Cycle cDNA Syn-
thesis Kit (Invitrogen). Microarray data were collected at the University Health
Network Facility (Toronto, ON) using GeneChip Human Genome U133 Plus 2.0
Arrays (Affymetrix). All GeneChips were scaled to a median intensity of 500,
and CEL files were normalized across all probe sets. Signal ratios were calcu-
lated compared to respective No Cre controls.
Immunoblot Analysis
Cells were lysed in RIPA buffer (150 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1%
deoxycholate, 0.1% SDS, 2 mM EDTA) supplemented with protease inhibitor
cocktail (Mini-Complete, Roche). Lysates were cleared by centrifugation for
15 min at 14,000 3 g. The protein content was determined by Bradford assay
(Quick Start, BioRad), and 50 mg were resolved by electrophoresis on 10%
SDS-polyacrylamide gels and transferred to PVDF membranes by electroblot-
ting. Immunoblotting was performed using antibodies reactive with Sox7
(1:500), Sox17 (1:500), or actin (Sigma AC-74; 1:5000), and reactivity was
detected using anti-mouse IgG HRP-conjugated secondary antibody (Jack-
son Laboratories; 1:5000).
Flow Cytometry
Monolayer cultures were dissociated and single-cell suspensions were ana-
lyzed on a FACSAria cell sorter (Becton Dickinson). For intracellular AFP stain-ing, cells were fixed (2% PFA) and stained with primary and Alexa Fluor 488
anti-mouse IgG in PBS containing 5% goat serum and 0.5% saponin (Sigma).
Staining with biotinylated anti-CXCR4 and PE anti-cKit (BD PharMingen) was
performed by incubation for 30 min on ice in PBS/5% goat serum and biotiny-
lated mAb revealed with streptavidin Alexa Fluor 488 (Molecular Probes).
ACCESSION NUMBERS
Microarray data have been deposited at NCBI GEO (series record GSE10809).
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